acut
hypoxem
respiratori
failur
ahrf
high
possibl
develop
acut
respiratori
distress
syndrom
ard
increas
death
risk
although
preval
ard
icu
admiss
syndrom
appear
underrecognis
undertr
associ
high
mortal
rate
essenti
recognit
ard
identifi
patient
ahrf
breath
aid
ventil
ahrf
repres
common
endpoint
multipl
patholog
process
either
local
system
may
mani
medic
condit
aetiolog
divid
less
main
determin
two
categori
pulmonari
extrapulmonari
tabl
list
common
caus
ahrf
pulmonari
determin
pneumonia
bacteri
viru
infect
diseas
frequent
diseas
associ
ahrf
extrapulmonari
sepsi
blood
transfus
pancreat
drug
reaction
frequent
extrapulmonari
caus
side
chronic
diseas
diabet
associ
lower
occurr
ard
moreov
demograph
environment
risk
factor
relat
develop
ard
includ
older
age
specif
genet
variant
chapter
review
medic
diseas
associ
ahrf
relat
treatment
option
incid
acut
lung
injuri
critic
ill
syndrom
consist
acut
hypoxem
respiratori
failur
bilater
pulmonari
infiltr
lung
increas
age
per
personyear
year
age
per
personyear
year
age
mortal
increas
age
patient
year
age
patient
year
age
older
rate
develop
ard
sever
sepsi
report
law
furthermor
ard
develop
develop
rapidli
associ
high
mortal
rate
initi
serum
lactat
measur
valid
clinic
predict
score
hospit
admiss
use
riskstratifi
patient
sever
sepsi
high
risk
ard
develop
viru
infect
ard
may
rare
complic
lung
infect
due
respiratori
virus
except
recent
pandem
influenza
virus
induc
sever
ard
specif
manag
includ
antivir
treatment
oseltamivir
influenza
virus
avoid
corticosteroid
seem
harm
ventilatori
manag
patient
virusinduc
ard
ard
etiolog
pandem
stimul
interest
extracorpor
membran
oxygen
ecmo
therapi
physiopatholog
role
infect
pneumoniaa
indirect
lung
injuri
well
known
variou
pathogen
caus
pneumonia
occasion
pneumonia
progress
ard
multipl
organ
failur
death
pathogen
caus
pneumonia
may
caus
ard
immunopathogenesi
ard
may
pneumonia
although
risk
factor
infant
elderli
comorbid
diseas
immunodefici
state
associ
develop
ard
variou
respiratori
infect
includ
influenza
viru
infect
previous
healthi
patient
also
develop
ard
addit
major
patient
infect
respiratori
pathogen
influenza
virus
mycoplasma
pneumonia
pneumonia
may
asymptomat
mild
symptom
differ
noninfecti
etiolog
condit
blunt
chest
contus
multipl
injuri
aspir
gastric
content
inhal
burn
pancreat
blood
transfus
may
caus
ard
although
pathogenesi
condit
remain
unknown
etiolog
substanc
induc
inflamm
immun
cell
induc
lung
cell
injuri
featur
secondari
ali
ard
involv
initi
exud
phase
diffus
alveolar
damag
microvascular
injuri
typei
pneumocyt
necrosi
influx
inflammatori
cell
follow
fibroprolif
phase
lung
repair
typeii
pneumocyt
hyperplasia
prolifer
fibroblast
mani
factor
welltrain
staff
age
chronic
diseas
burden
nonpulmonari
organ
dysfunct
shock
hepat
failur
influenc
prognosi
persist
hypoxemia
greater
predict
valu
ali
mortal
often
report
fortun
improv
mortal
declin
recent
year
probabl
advanc
mechan
ventil
treatment
sepsi
acut
hypoxem
arf
possibl
increas
fio
level
sever
method
highflow
nasal
therapi
hfnot
nonrebreath
mask
applic
invasivenoninvas
mv
ecmo
extracorpor
membran
oxygen
period
allow
time
cur
treatment
recent
evid
show
patient
moder
sever
ard
strategi
lung
recruit
titrat
peep
compar
low
peep
increas
allcaus
mortal
furthermor
find
support
routin
use
lung
recruit
manoeuvr
peep
titrat
patient
manag
acut
respiratori
failur
requir
integr
support
escal
therapeut
strategi
furthermor
current
use
niv
altern
invas
ventil
sever
hypoxem
patient
ard
gener
recommend
niv
limit
highli
select
haemodynam
stabl
patient
close
monitor
intens
care
set
highli
skill
staff
readi
promptli
intub
oxygen
fail
improv
suffici
within
first
hour
new
therapi
highflow
oxygen
therapi
allow
administr
warm
humidifi
ga
highflow
rate
therapi
improv
patient
oxygen
minimis
advers
effect
main
benefit
system
patient
comfort
